Please login to the form below

Not currently logged in
Email:
Password:

Exscientia

This page shows the latest Exscientia news and features for those working in and with pharma, biotech and healthcare.

BMS links up with Exscientia for $1.2bn AI drug discovery deal

BMS links up with Exscientia for $1.2bn AI drug discovery deal

Exscientia’s application of AI technologies is proving capable of generating best-in-class molecules while also reducing discovery times. ... technologies and drug discovery expertise,” said Andrew Hopkins, chief executive officer of Exscientia.

Latest news

More from news
Approximately 6 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • A snapshot of… Exscientia A snapshot of… Exscientia

    At Exscientia, we uniquely apply AI and machine learning with experiments in order to accelerate the discovery of new clinic-ready compounds. ... What impact is the planned Brexit having on the company? For Exscientia, access to great talent is vital.

  • AI and genomics: a revolution in drug discovery and development AI and genomics: a revolution in drug discovery and development

    Likewise, Sanofi has partnered with Exscientia to use its artificial intelligence technology to find potentials targets for metabolic disease therapies.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...